ISSN: 2040-2503

Journal Home

Journal Guideline

MedChemComm Q1 Unclaimed

Royal Society of Chemistry United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

MedChemComm is a journal indexed in SJR in Biochemistry and Drug Discovery with an H index of 49. It has a best quartile of Q1.

MedChemComm focuses its scope in these topics and keywords: activity, derivatives, inhibitor, drug, biological, constrained, cytotoxicity, detection, conformationally, cyclic, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q1) Drug Discovery (Q2) Organic Chemistry (Q2) Pharmacology (Q2) Biochemistry (Q3) Molecular Medicine (Q3)

Price

- €

Inmediate OA

0 €

Embargoed OA

- €

Non OA

Metrics

-

SJR Impact factor

49

H Index

194

Total Docs (Last Year)

707

Total Docs (3 years)

10426

Total Refs

1875

Total Cites (3 years)

668

Citable Docs (3 years)

283

Cites/Doc (2 years)

5374.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annual Review of Biochemistry Q1
Nature Protocols Q1
Chem Q1
Annals of the Rheumatic Diseases Q1
Developmental Cell Q1

Compare this journals

Aims and Scope

Best articles by citations

Discovery of novel 5-fluoro-N2,N4-diphenylpyrimidine-2,4-diamines as potent inhibitors against CDK2 and CDK9

Fragment growing exploiting dynamic combinatorial chemistry of inhibitors of the aspartic protease endothiapepsin

Anti-bacterial glycosyl triazoles -identification of an N-acetylglucosamine derivative with bacteriostatic activity against Bacillus

Druggability assessment of mammalian Per-Arnt-Sim [PAS] domains using computational approaches

The effect of N-methylation on transition state mimetic inhibitors of the Plasmodium protease, plasmepsin V

Synthesis and evaluation of linear CuAAC-oligomerized antifreeze neo-glycopeptides

Synthesis of unusual isoxazoline containing beta and gamma-dipeptides as potential glutamate receptor ligands

Expansion of the structure-activity relationships of BACE1 inhibitors by harnessing diverse building blocks prepared using a unified synthetic approach

Exploring cinnamic acid scaffold: development of promising neuroprotective lipophilic antioxidants

Application of QM/MM and QM methods to investigate histone deacetylase 8

Microwave-assisted regioselective direct C-H arylation of thiazole derivatives leading to increased s1 receptor affinity

Discovery of novel sphingosine kinase 1 inhibitorsvia structure-based hierarchical virtual screening

SHOW MORE ARTICLES

Synthesis and evaluation of phenoxymethylbenzamide analogues as anti-trypanosomal agents

Understanding the structural requirements of hybrid (S)-6-((2-(4-phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol and its analogs as D2/D3 receptor ligands: a 3D QSAR investigation

A fundamental view of enthalpy-entropy compensation

Targeting S. mutans biofilms: a perspective on preventing dental caries

A novel surface-coated nanocarrier for efficient encapsulation and delivery of camptothecin to cells

Evaluation of binding competition and group epitopes of acetylcholinesterase inhibitors by STD NMR, Tr-NOESY, DOSY and molecular docking: an old approach but new findings

SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc1 inhibitors

Investigation of novel ropinirole analogues: synthesis, pharmacological evaluation and computational analysis of dopamine D2 receptor functionalized congeners and homobivalent ligands

Photophysical properties and application in live cell imaging of B,B-fluoro-perfluoroalkyl BODIPYs

A mechanistic study on the a-N-acetylgalactosaminidase from E. meningosepticum: a family 109 glycoside hydrolase

Substituted 4-hydroxy-1,2,3-triazoles: synthesis, characterization and first drug design applications through bioisosteric modulation and scaffold hopping approaches

Label-free technologies for target identification and validation